ANAB NASDAQ
AnaptysBio, Inc.
1W: -2.9%
1M: +12.8%
3M: +11.5%
YTD: +34.4%
1Y: +186.3%
3Y: +224.3%
5Y: +131.5%
$59.71
-0.70 (-1.16%)
Weekly Expected Move ±13.3%
$46
$55
$63
$72
$80
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$232M
Revenue
+107.7% YoY
$-27M
Net Income
+81.0% YoY
$4M
Free Cash Flow
+104.0% YoY
97.6%
Gross Margin
-135.5%
Op. Margin
-206.9%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-49.6%
ROA-6.3%
ROIC-12.4%
Valuation
P/E-63.8
P/B134.1
EV/EBITDA24.3
Leverage
Debt/Equity0.38
Current Ratio9.07
Interest Cov.0.6x
Quality Scores
Piotroski F6/9
Altman Z2.07
Beneish M-4.51